Diagnostic utility and sensitivity of the IGF-1 generation test in children and adolescents with growth disorders: A comparative review with GH stimulation tests
Utility and sensitivity of IGF-1 generation test
Keywords:
IGF-1 generation test, growth hormone deficiency, pediatric growth disorders in children and adolescents, GH stimulation test, diagnostic sensitivity, biomarkers of GH response.Abstract
Background: The IGF-1 (Insulin-like Growth Factor 1) generation test has been widely used in diagnosing growth hormone disorders. However, the diagnostic utility of this test remains debated due to variability in protocols, cut-off points, and sensitivity compared to other methods, particularly the GH stimulation test. Objective: This review seeks to assess the diagnostic value of the IGF-1 generation test (IGF-1 GT) across different growth and puberty-related disorders, the applications across different patient populations, and the diagnostic accuracy in comparison to GH stimulation test. Methods: A comprehensive literature search was conducted across electronic databases (PubMed, Scopus, Web of Science) from 1994 to 2024. Studies were included if they evaluated the IGF-1 GT in diagnosing growth disorders in pediatric populations. IGF-1 cut-off values, test protocols, and diagnostic sensitivity were extracted and compared to those of the GH stimulation test. Results: The IGF-1 GT showed variable sensitivity depending on the diagnosed condition. The IGF-1 GT sensitivity ranged from 30-60%. When compared to the GH stimulation test, which has a sensitivity of 90-100% for diagnosing growth hormone deficiency (GHD), the IGF-1 GT showed a moderate sensitivity (70-90%) and less reliability for idiopathic short stature, Turner Syndrome and Laron Syndrome. Conclusion: The IGF-1 GT is a valuable tool in diagnosing GHD and partial GH insensitivity in specific syndromic disorders, though it illustrates variable sensitivity across different conditions. This variability and differences in testing protocols emphasize the need for further standardization and comparative research with the recombinant GH stimulation test.
References
Stanley T, Bhatia B, Loche S, et al. Diagnosis of growth hormone deficiency in childhood. J Clin Endocrinol Metab. 2014;99(11):4132-4138. doi:10.1210/jc.2014-1568.
Cohen P, Rogol AD, Deal CL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: A summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Pediatric Endocrinology Workshop. J Pediatr Endocrinol Metab. 2008;21(6):607-610. doi:10.1515/ JPEM. 2008.21.6.607.
Laron Z, Kauli R. Fifty-seven years of follow-up of the Israeli cohort of Laron Syndrome patients - From discovery to treatment. Horm Res Paediatr. 2016;85(3):193-202. doi:10.1159/000443503.
Bozzola M, Chiesa S, et al. Impaired IGF-1 response linked to protein-energy malnutrition. J Pediatr Endocrinol Metab. 1997;10(1):37-41. doi:10.1515/JPEM.1997.10.1.37.
Finken MJ, Keijzer-Veen MG, et al. Reduced IGF-1 generation both at baseline and after stimulation in small for gestational age infants. J Clin Endocrinol Metab. 2006;91(9):3285-3290. doi:10.1210/jc.2006-0643.
Rosenfeld RG, Attie KM, et al. Reduced IGF-1 generation in Turner syndrome patients in response to GH therapy. J Clin Endocrinol Metab. 1998;83(2):482-485. doi:10.1210/jcem.83.2.4614.
Colle M, Carel J, et al. Normal IGF-1 generation, no underlying GH insensitivity in idiopathic short stature. Horm Res.1999;51(2):102-108. doi:10.1159/000023315.
Soliman AT, De Sanctis V, Khater D. Constitutional delay of growth and puberty: A cross-sectional and longitudinal study of serum IGF-1 and IGFBP-3 levels. Ann Pediatr Endocrinol Metab. 2014;19(1):5-11. doi:10.6065/apem.2014.19.1.5.
Binder G, Ranke MB. Reduced IGF-1 generation linked to GH insensitivity in Noonan syndrome. Horm Res. 2005;64(3):131-136. doi:10.1159/000087718.
Ghigo E, Aimaretti G, et al. Reduced IGF-1 generation in response to rhGH in growth hormone deficiency. J Clin Endocrinol Metab. 2000;85(11):3984-3988. doi:10.1210/jcem.85.11.6944.
Stanley TL, Grinspoon SK. Blunted or minimal IGF-1 increase in GHD children after GH stimulation. J Clin Endocrinol Metab. 2015;100(8):3179-3188. doi:10.1210/jc.2015-1825.
Katznelson L, Laws ER, Melmed S, et al. Acromegaly: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933-3951. doi:10.1210/jc.2014-2700.
Hellström A, Sigurdsson J, Löfqvist C, et al. Lower IGF-I and elevated IGF-II levels in preterm infants born SGA. Growth Horm IGF Res. 2020;51:46-57. doi:10.1016/j.ghir.2020.03.002.
Taback SP, Guyda HJ. Constitutional delay of puberty: a study of basal insulin-like growth factor-I and binding protein levels. J Pediatr. 1994;124(2):150-157. doi:10.1016/S0022-3476(94)70319-5.
Boguszewski M, Karlberg J, Albertsson-Wikland K. Insulin-like growth factor-1 in short children born small for gestational age. Horm Res Paediatr. 1995;43(6):278-284. doi:10.1159/000184240.
Bozzola M, Chiesa S, et al. Impaired IGF-1 response linked to protein-energy malnutrition. J Pediatr Endocrinol Metab. 1997;10(1):37-41. doi:10.1515/jpem.1997.10.1.37.
Misra M, Levitsky LL, Miller KK. Normal or near-normal IGF-1 increase in idiopathic short stature patients. Front Endocrinol (Lausanne). 2012;3:86. doi:10.3389/fendo.2012.00086.
Cianfarani S, Tato L, et al. Growth hormone deficiency and IGF-I levels. J Endocrinol Invest. 2002;25(5):449-455. doi:10.1007/BF03343990.
Stanley TL, Grinspoon SK. Blunted or minimal IGF-1 increase in GHD children after GH stimulation. J Clin Endocrinol Metab. 2015;100(8):3179-3188. doi:10.1210/jc.2015-1825.
Kim J, Kim S, Lee J, et al. Insulin-like growth factor-I in idiopathic growth hormone deficiency, Turner syndrome, and SGA. J Endocr Soc. 2020;4(3):1-9. doi:10.1210/jendso/bvaa011.
Kim MH, Kim EY, Kim HS. Investigating whether serum IGF-1 and IGFBP-3 levels reflect growth hormone responsiveness in children with short stature. Horm Res Paediatr. 2021;93 (1):10-16. doi:10.1159/000510623.
Coutant R, Dörr HG, Gleeson H, Argente J. Diagnosis of endocrine disease: limitations of the IGF-1 generation test in children with short stature. Eur J Endocrinol. 2012;166(3):351-357. doi:10.1530/EJE-11-0618.
Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP, Rosenfeld RG. The IGF-I generation test revisited: a marker of GH sensitivity. J Clin Endocrinol Metab. 2001;86(11):5176-5183. doi:10.1210/jcem.86.11.8019.
Perez-Colon S, Lazareva O, Purushothaman R, Malik S, Ten S, Bhangoo A. Baseline IGFBP-3 as a key element to predict growth response to GH and IGF-1 therapy in children with non-GHD short stature and IGF-1 deficiency. Int J Endocrinol Metab. 2018;16(3) . doi:10.5812/ijem.63169.
De Sanctis V, Elsedfy H, Soliman AT, et al. Diminished IGF-1 response due to GH resistance from iron overload in thalassemia major. Indian J Endocrinol Metab. 2013;17(2):318-320. doi:10.4103/2230-8210.109718.
Beserra ICR, Ribeiro M, Damiani D, et al. Normal IGF-1 generation in children with Silver-Russell Syndrome. Int J Pediatr Endocrinol. 2010;2010:670642. doi:10.1155/2010/670642.
Iñiguez G, Ong K, Bazaes R, Avila A, Salazar T, Dunger D, Mericq V. Longitudinal changes in insulin-like growth factor-I, insulin sensitivity, and secretion from birth to age three years in small-for-gestational-age children. J Clin Endocrinol Metab. 2006;91(11):4645-4649. doi:10.1210/jc.2006-0844.
Smyczynski C, Rychlowska-Himmel I, Hilczer M, et al. IGF-1 and IGFBP-3 in the assessment of growth hormone secretion in short stature children. Neuro Endocrinol Lett. 2013;34(5):420-424.
Blum W, Rosberg S, Ranke M, Albertsson-Wikland K. The short-term increases of IGF-I and IGFBP-3 during GH treatment predict the long-term growth response in short children. Pediatr Res. 1993;33(Suppl 4):464-471. doi:10.1203/00006450-199304001-00161.
Ranke MB, Lindberg A, Cowell CT, et al. International database on growth hormone treatment in children and adolescents: KIGS. Horm Res Paediatr. 2005;63(Suppl 1):212-221. doi:10.1159/ 000084790.
Ranke MB, Lindberg A, Price DA, Reiter EO, Albertsson-Wikland K, Wilton P. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in Turner syndrome. Endocr Rev. 2007;28(4):477-514. doi:10.1210/er.2006-0041.
Ranke MB, Bierich JR, Brosicke H, et al. Diagnostic efficacy of the IGF-1 generation test in Turner syndrome: Moderate sensitivity and limitations due to normal GH response. Endocr Rev. 1993;14(2):168-172. doi:10.1210/edrv-14-2-168.
Tonshoff B, Mehls O. Growth retardation in children with chronic kidney disease: IGF-1 and growth hormone therapy. Pediatr Nephrol. 2006;21(6):783-789. doi:10.1007/s00467-005-2096-3.
Goldstone AP, Holland AJ, Butler JV, Whittington JE. Prader-Willi syndrome: Advances in genetics, pathophysiology and treatment. Nat Rev Endocrinol. 2008;4(1):25-34. doi:10.1038/ncpendmet0724.
Fisher DA, Brown RS. Thyroid function and growth hormone axis in congenital hypothyroidism. Thyroid. 1996;6(2):179-183. doi:10.1089/thy.1996.6.179.
Stróżewska W, Durda-Masny M, Szwed A. Mutations in GHR and IGF1R genes as a potential reason for the lack of catch-up growth in SGA children. Genes. 2022;13(5):856. doi:10.3390/ genes13050856.
Göpel E, Rockstroh D, Pfäffle H, et al. A comprehensive cohort analysis comparing growth and GH therapy response in IGF1R mutation carriers and SGA children. J Clin Endocrinol Metab. 2020;105(4). doi:10.1210/clinem/dgz165.
Apel A, Iliev D, Urban C, et al. GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature. Front Endocrinol. 2022;13:897897. doi:10.3389/fendo.2022.897897.
Kawashima-Sonoyama Y, Hotsubo T, Hamajima T, et al. Various phenotypes of short stature with heterozygous IGF-1 receptor (IGF1R) mutations. Clin Pediatr Endocrinol. 2022;31(2):59-67. doi:10.1297/cpe.2021-0064.
Shapiro MR, Foster T, Perry D, et al. A novel mutation in insulin-like growth factor 1 receptor (c.641-2A>G) is associated with impaired growth, hypoglycemia, and modified immune phenotypes. Horm Res Paediatr. 2020;93(5-6):322-334. doi:10.1159/000510764.
Iwayama H, Hasegawa Y, Onodera K, et al. Accuracy of IGF-1 Screening for Diagnosing Growth Hormone Deficiency. Endocr J. 2021;68(3):225-233. doi:10.1507/endocrj.EJ20-0553.
Rath S, Hubenthal M, Bansal R, et al. SAT-106 Growth Hormone Treatment Response in Children with Idiopathic Short Stature: Association with Baseline Characteristics and Endocrine Markers. Endocr Rev. 2020;41(Suppl 2):273. doi:10.1210/jendso/bvaa046.273.
Agrawal R, Pavithran PV, Bhavani N, et al. Role of IGF-1 as a predictor of outcomes for GH-stimulation testing. Indian J Endocrinol Metab. 2022;26(1):82-82. doi:10.4103/2230-8210.363699.
Cong M, Qiu S, Li R, Sun H, Cong L, Hou Z. Development of a predictive model of growth hormone deficiency and idiopathic short stature in children. Exp Ther Med. 2021;21:1-10. doi:10.3892/etm.2021.9925.
Inoue-Lima TH, Vasques GA, Nakaguma M, et al. A Bayesian approach to diagnose growth hormone deficiency in children: insulin-like growth factor type 1 is valuable for screening and IGF-binding protein type 3 for confirmation. Horm Res Paediatr. 2020;93(3):197-205. doi:10.1159/000509840.
Obara-Moszyńska M, Kctdzia A, Korman E, Niedziela M. Usefulness of Growth Hormone (GH) stimulation tests and IGF-1 concentration measurement in GH deficiency diagnosis. J Pediatr Endocrinol Metab. 2008;21(6):569-580. doi:10.1515/jpem-2008-210611.
Haj-Ahmad LM, Mahmoud MM, Sweis NW, Bsisu IK, Alghrabli AM, Ibrahim AM, Zayed AA. Serum IGF-1 to IGFBP-3 molar ratio: a promising diagnostic tool for growth hormone deficiency in children. J Clin Endocrinol Metab. 2022;107(6). doi:10.1210/clinem/dgaa609.
Fatani T. Diagnostic value of IGF-1 in growth hormone–deficient children: is a second growth hormone stimulation test necessary? J Endocr Soc. 2023;7:1-8. doi:10.1210/jendso/bvad018.
Smyczyńska J, Smyczyńska U, Hilczer M, Stawerska R, Lewiński A. Significance of direct confirmation of growth hormone insensitivity for the diagnosis of primary IGF-I deficiency. J Clin Med. 2020;9:240. doi:10.3390/jcm9010240.
Ravi Teja KV, Malhotra B, Vogel M, et al. Normative data for insulin-like growth factor-1 (IGF-1) in healthy children and adolescents from India. J Clin Endocrinol Metab. Published online May 15, 2024. doi:10.1210/clinem/dgae340.
Giannakopoulos A, Efthymiadou A, Chrysis D. Insulin-like growth factor ternary complex components as biomarkers for the diagnosis of short stature. Eur J Endocrinol. 2021;184(1):25-30. doi:10.1530/EJE-21-0475.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ashraf T Soliman, Fawzia Alyafei, Shayma Ahmed, Noora AlHumaidi , Noor Hamed, Ahmed Elawwa, Nada Alaaraj, Ahmed Khalil, Vincenzo De Sanctis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
